Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.58 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | MAOA | P21397 | 3/20 | 0.48 |
| ▸ | MAOB | P27338 | 3/20 | 0.48 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6163270 | 0.89 | SPHK1 (0.47) | SPHK1SPHK2NPC1RAB9A | |
| SCHEMBL7371918 | 0.86 | ADAM17 (0.49) | SPHK1SPHK2NPC1RAB9AMAOA | |
| SCHEMBL3138570 | 0.85 | SPHK1 (0.50) | SPHK1SPHK2NPC1RAB9A | |
| SCHEMBL8190796 | 0.84 | SPHK1 (0.48) | SPHK1SPHK2NPC1RAB9AMAOA | |
| SCHEMBL7403639 | 0.84 | NPC1 (0.46) | SPHK1SPHK2NPC1RAB9AMAOA | |
| SCHEMBL7365257 | 0.83 | SPHK1 (0.50) | SPHK1SPHK2NPC1RAB9AMAOA | |
| SCHEMBL7370196 | 0.83 | NPC1 (0.55) | SPHK1NPC1RAB9AMAOBHRH3 | |
| SCHEMBL7341840 | 0.80 | SPHK1 (0.54) | SPHK1SPHK2NPC1RAB9AMAOA | |
| SCHEMBL7371853 | 0.77 | LTA4H (0.54) | NPC1RAB9AHRH3HTT | |
| SCHEMBL7371153 | 0.77 | SPHK1 (0.57) | SPHK1SPHK2NPC1RAB9AMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6117841-A | USED TO TREAT STROKE, CEREBRAL ISCHEMIA, PAIN, HEAD TRAUMA OR EPILEPSY | WARNER-LAMBERT COMPANY (US) | 2000-09-12 | — | — | US | claimed |
| WO-1998054123-A1 | SUBSTITUTED PEPTIDYLAMINE CALCIUM CHANNEL BLOCKERS | WARNER-LAMBERT COMPANY (US) | 1998-12-03 | — | — | WO | claimed |
| US-6117841-A | USED TO TREAT STROKE, CEREBRAL ISCHEMIA, PAIN, HEAD TRAUMA OR EPILEPSY | WARNER-LAMBERT COMPANY (US) | 2000-09-12 | — | — | US | disclosed |
| WO-1998054123-A1 | SUBSTITUTED PEPTIDYLAMINE CALCIUM CHANNEL BLOCKERS | WARNER-LAMBERT COMPANY (US) | 1998-12-03 | — | — | WO | disclosed |